Status:
COMPLETED
Minimum Intervention to Maintain a Postpartum Depression Prevention Program in Clinics Serving Low-income Women
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
Butler Hospital
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions:
Depression, Postpartum
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Postpartum depression (PPD) is common and can have lasting consequences for mother and child. ROSE is an intervention to prevent PPD, delivered during pregnancy in outpatient prenatal settings. ROSE h...
Detailed Description
A recent expert consensus report concluded that, "Little is known about how well or under what conditions health innovations are sustained and their gains maintained once they are put into practice. I...
Eligibility Criteria
Inclusion
- Study enrollment and randomization takes place at the clinic level. Study participants will be clinical and operational staff representatives of participating clinics.
- To be included in the study, clinics will:
- provide outpatient prenatal services
- estimate that at least 50% of their pregnant patients receive some kind of public assistance (such as federal or state assistance in the form of cash assistance such as Temporary Assistance for Needy Families \[TANF\], food stamps, subsidized housing, and/or health care such as Medicaid)
- have at least 10 new pregnant women per month on average (i.e., enough patient flow to run ROSE)
- agree to study procedures.
- Exclusion Criteria:
- None
Exclusion
Key Trial Info
Start Date :
June 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
791 Patients enrolled
Trial Details
Trial ID
NCT03267563
Start Date
June 12 2018
End Date
December 31 2023
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan State University
Flint, Michigan, United States, 48502